Patent US5187263A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5187263A Expired / Lapsed US ⏱️ 0.0 years remaining

Expression of biologically active PDGE analogs in eucaryotic cells

Assignee: Zymogenetics Inc
•
Filing: 1992-01-02
•
Granted: 1993-02-16
•
Expires: 2012-01-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods for expressing a variety of biologically active PDGF analogs in eucaryotic cells are disclosed. The methods generally comprise introducing into a eucaryotic host cell a DNA construct capable of directing the expression and secretion of biologically active PDGF analogs in eucaryotic cells. The DNA construct contains a transcriptional promoter followed downstream by a suitable DNA sequence. The DNA sequence may encode a protein substantially homologous to the A-chain or the B-chain of PDGF, or a portion thereof, or an A-B heterodimer. In addition, a portion of the DNA sequence may encode at least a portion of the A-chain, while another portion encodes at least a portion of the B-chain of PDGF. Eucaryotic cells transformed with these DNA constructs are also disclosed. Methods of promoting the growth of mammalian cells, comprising incubating the cells with a biologically active PDGF analog expressed by a eucaryotic host cell transformed with such a DNA construct, are also disclosed.

Inventors

  • 👤 Mark J. Murray
  • 👤 James D. Kelly

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 07:08
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/005; C07K14/435; C07K14/475; C07K14/49; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/62; C12N15/625; C12N15/63; C12N15/79; C12N15/80; C12N15/81; A; A61; A61K; A61K38/00; C07K2319/00; C07K2319/01; C07K2319/02; C07K2319/036; C07K2319/70; C07K2319/74; C07K2319/75; C12N2740/00; C12N2740/00011; C12N2740/10011; C12N2740/11011; C12N2740/11022

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 75 words
A mitogenic protein produced by a method comprising: (a) introducing into a eucaryotic host cell a DNA construct capable of directing the expression and secretion of biologically active PDGF analogs in eucaryotic cells, said DNA construct containing a transcriptional promoter followed downstream by a DNA sequence that encodes the B-chain of a primate PDGF; and (b) isolating from the host cell a mitogenic protein, which is a PDGF BB Romodimer, expressed from said DNA construct.
Claim 2
Dependent Claim 75 words
A mitogenic protein produced by a method comprising: (a) introducing into a eucaryotic host cell a DNA construct capable of directing the expression and secretion of biologically active PDGF analogs in eucaryotic cells, said DNA construct containing a transcriptional promoter followed downstream by a DNA sequence that encodes the B-chain of a primate PDGF; and (b) isolating from the host cell a mitogenic protein, which is a PDGF BB Romodimer, expressed from said DNA construct.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-02-16 1996-08-17 1997-02-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-02-16 2000-08-17 2001-02-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-02-16 2004-08-17 2005-02-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag